Patrizia Nanni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

University of Bologna

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bologna Oct 01 2002

Italy

Associate Professor :: Department of Experimental, Diagnostic and Specialty Medicine (DIMES)

Publications

Francesca Ruzzi, Maria Sofia Semprini, Laura Scalambra, Arianna Palladini, Stefania Angelicola, Chiara Cappello, Olga Maria Pittino, Patrizia Nanni, Pier-Luigi Lollini
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy. International journal of molecular sciences 24 (16) (2023)
Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, Giordano Nicoletti, Patrizia Nanni, Pier-Luigi Lollini
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy. Cells 10 (7) (2021)
Stefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, Laura Scalambra, Francesco Gelsomino, Andrea Ardizzoni, Patrizia Nanni, Pier-Luigi Lollini, Arianna Palladini
IFN-γ and CD38 in Hyperprogressive Cancer Development. Cancers 13 (2) (2021)
Veronica Giusti, Francesca Ruzzi, Lorena Landuzzi, Marianna L Ianzano, Roberta Laranga, Elena Nironi, Laura Scalambra, Giordano Nicoletti, Carla De Giovanni, Martina Olivero, Maddalena Arigoni, Raffaele Calogero, Patrizia Nanni, Arianna Palladini, Pier-Luigi Lollini
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression. Oncogenesis 10 (11) (2021)
Carla De Giovanni, Lorena Landuzzi, Arianna Palladini, Marianna Lucia Ianzano, Giordano Nicoletti, Francesca Ruzzi, Augusto Amici, Stefania Croci, Patrizia Nanni, Pier-Luigi Lollini
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R. Cancers 11 (4) (2019)
Carla De Giovanni, Patrizia Nanni, Lorena Landuzzi, Marianna L Ianzano, Giordano Nicoletti, Stefania Croci, Arianna Palladini, Pier-Luigi Lollini
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis. BMC cancer 19 (1) (2019)
Patrizia Nanni, Carla De Giovanni, Alessia Burocchi, Giordano Nicoletti, Lorena Landuzzi, Arianna Palladini, Marianna Lucia Ianzano, Ivano Arioli, Mario Paolo Colombo, Pier-Luigi Lollini
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis. Oncoimmunology 7 (8) (2018)

Patrizia Nanni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Patrizia Nanni